These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8844448)

  • 21. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.
    Bryson A; de la Motte S; Dunk C
    Br J Clin Pharmacol; 2009 Mar; 67(3):309-15. PubMed ID: 19220279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat.
    Hussain Y; Güzelhan C; Odink J; van der Beek EJ; Hartmann D
    J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men.
    Pace DG; Blotner S; Guerciolini R
    J Nutr; 2001 Jun; 131(6):1694-9. PubMed ID: 11385055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect on dietary fat absorption of orlistat, administered at different times relative to meal intake.
    Hartmann D; Hussain Y; Güzelhan C; Odink J
    Br J Clin Pharmacol; 1993 Sep; 36(3):266-70. PubMed ID: 9114915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects.
    O'Donovan D; Feinle-Bisset C; Wishart J; Horowitz M
    Br J Nutr; 2003 Nov; 90(5):849-52. PubMed ID: 14667178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
    Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z
    Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A one-year trial to assess the value of orlistat in the management of obesity.
    James WP; Avenell A; Broom J; Whitehead J
    Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S24-30. PubMed ID: 9225173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.
    Di Marco M; Marier JF; Ducharme MP; Morin I; Engel C; Gulbranson S; Thudi NR; Murpani D; Rampal A; Monif T; Koundinya TS; Deo K; Monif T
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):319-26. PubMed ID: 18541129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
    Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
    Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor.
    Borovicka J; Schwizer W; Guttmann G; Hartmann D; Kosinski M; Wastiel C; Bischof-Delaloye A; Fried M
    Gut; 2000 Jun; 46(6):774-81. PubMed ID: 10807887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.
    Weber C; Tam YK; Schmidtke-Schrezenmeier G; Jonkmann JH; van Brummelen P
    Eur J Clin Pharmacol; 1996; 51(1):87-90. PubMed ID: 8880057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
    Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH
    Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.
    Reitsma JB; Castro Cabezas M; de Bruin TW; Erkelens DW
    Metabolism; 1994 Mar; 43(3):293-8. PubMed ID: 8139476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal.
    Goedecke JH; Barsdorf M; Beglinger C; Levitt NS; Lambert EV
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1479-85. PubMed ID: 14634678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orlistat--a novel weight loss therapy.
    Lucas KH; Kaplan-Machlis B
    Ann Pharmacother; 2001 Mar; 35(3):314-28. PubMed ID: 11261530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipase inhibitor orlistat decreases incorporation of eicosapentaenoic and docosahexaenoic acids in rat tissues.
    Cruz-Hernandez C; Oliveira M; Pescia G; Moulin J; Masserey-Elmelegy I; Dionisi F; Destaillats F
    Nutr Res; 2010 Feb; 30(2):134-40. PubMed ID: 20226999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Processing of vitamin A and E in the human gastrointestinal tract.
    Borel P; Pasquier B; Armand M; Tyssandier V; Grolier P; Alexandre-Gouabau MC; Andre M; Senft M; Peyrot J; Jaussan V; Lairon D; Azais-Braesco V
    Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G95-G103. PubMed ID: 11123202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.
    Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT
    Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.